Combination and sequential treatments in the management of osteoporosis

por Papapoulos, Socrates
Publicado 2012

Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis

por Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E.
Publicado 2015

Sclerostin Inhibition in the Management of Osteoporosis

por Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E.
Publicado 2016

From disease to treatment: from rare skeletal disorders to treatments for osteoporosis

por Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E.
Publicado 2016

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of...

por Anastasilakis, Athanasios D., Makras, Polyzois, Paccou, Julien, Bisbinas, Ilias, Polyzos, Stergios A., Papapoulos, Socrates E.
Publicado 2023

Increased Bone Resorption during Lactation in Pycnodysostosis

por Jansen, Ineke D.C., Papapoulos, Socrates E., Bravenboer, Nathalie, de Vries, Teun J., Appelman-Dijkstra, Natasha M.
Publicado 2021

Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)(2) Vitamin D3 Treatment

por Thijs, Willemien, Janssen, Kirsten, van Schadewijk, Annemarie M., Papapoulos, Socrates E., le Cessie, Saskia, Middeldorp, Saskia, Melissant, Christian F., Rabe, Klaus F., Hiemstra, Pieter S.
Publicado 2015

Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe

por McCloskey, Eugene, Rathi, Jeetandera, Heijmans, Stephane, Blagden, Mark, Cortet, Bernard, Czerwinski, Edward, Hadji, Peyman, Payer, Juraj, Palmer, Kerry, Stad, Robert, O’Kelly, James, Papapoulos, Socrates
Publicado 2022

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

por Adachi, Jonathan D., Bone, Henry G., Daizadeh, Nadia S., Dakin, Paula, Papapoulos, Socrates, Hadji, Peyman, Recknor, Chris, Bolognese, Michael A., Wang, Andrea, Lin, Celia J. F., Wagman, Rachel B., Ferrari, Serge
Publicado 2017

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

por van Bezooijen, Rutger L., Roelen, Bernard A.J., Visser, Annemieke, van der Wee-Pals, Lianne, de Wilt, Edwin, Karperien, Marcel, Hamersma, Herman, Papapoulos, Socrates E., ten Dijke, Peter, Löwik, Clemens W.G.M.
Publicado 2004

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

por Bone, Henry G, Cosman, Felicia, Miller, Paul D, Williams, Gregory C, Hattersley, Gary, Hu, Ming-yi, Fitzpatrick, Lorraine A, Mitlak, Bruce, Papapoulos, Socrates, Rizzoli, René, Dore, Robin K, Bilezikian, John P, Saag, Kenneth G
Publicado 2018

Five Years of Cenosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension

por Papapoulos, Socrates, Chapurlat, Roland, Libanati, Cesar, Brandi, Maria Luisa, Brown, Jacques P, Czerwiński, Edward, Krieg, Marc-Antoine, Man, Zulema, Mellström, Dan, Radominski, Sebastião C, Reginster, Jean-Yves, Resch, Heinrich, Ivorra, José A Román, Roux, Christian, Vittinghoff, Eric, Austin, Matthew, Daizadeh, Nadia, Bradley, Michelle N, Grauer, Andreas, Cummings, Steven R, Bone, Henry G
Publicado 2012

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

por Bone, Henry G., Chapurlat, Roland, Brandi, Maria-Luisa, Brown, Jacques P., Czerwiński, Edward, Krieg, Marc-Antoine, Mellström, Dan, Radominski, Sebastião C., Reginster, Jean-Yves, Resch, Heinrich, Ivorra, Jose A. Román, Roux, Christian, Vittinghoff, Eric, Daizadeh, Nadia S., Wang, Andrea, Bradley, Michelle N., Franchimont, Nathalie, Geller, Michelle L., Wagman, Rachel B., Cummings, Steven R., Papapoulos, Socrates
Publicado 2013